Rapid clearance of storage-induced microerythrocytes alters transfusion recovery.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
29 04 2021
Historique:
received: 05 08 2020
accepted: 16 01 2021
pubmed: 4 3 2021
medline: 15 12 2021
entrez: 3 3 2021
Statut: ppublish

Résumé

Permanent availability of red blood cells (RBCs) for transfusion depends on refrigerated storage, during which morphologically altered RBCs accumulate. Among these, a subpopulation of small RBCs, comprising type III echinocytes, spheroechinocytes, and spherocytes and defined as storage-induced microerythrocytes (SMEs), could be rapidly cleared from circulation posttransfusion. We quantified the proportion of SMEs in RBC concentrates from healthy human volunteers and assessed correlation with transfusion recovery, investigated the fate of SMEs upon perfusion through human spleen ex vivo, and explored where and how SMEs are cleared in a mouse model of blood storage and transfusion. In healthy human volunteers, high proportion of SMEs in long-stored RBC concentrates correlated with poor transfusion recovery. When perfused through human spleen, 15% and 61% of long-stored RBCs and SMEs were cleared in 70 minutes, respectively. High initial proportion of SMEs also correlated with high retention of RBCs by perfused human spleen. In the mouse model, SMEs accumulated during storage. Transfusion of long-stored RBCs resulted in reduced posttransfusion recovery, mostly due to SME clearance. After transfusion in mice, long-stored RBCs accumulated predominantly in spleen and were ingested mainly by splenic and hepatic macrophages. In macrophage-depleted mice, splenic accumulation and SME clearance were delayed, and transfusion recovery was improved. In healthy hosts, SMEs were cleared predominantly by macrophages in spleen and liver. When this well-demarcated subpopulation of altered RBCs was abundant in RBC concentrates, transfusion recovery was diminished. SME quantification has the potential to improve blood product quality assessment. This trial was registered at www.clinicaltrials.gov as #NCT02889133.

Identifiants

pubmed: 33657208
pii: S0006-4971(21)00518-8
doi: 10.1182/blood.2020008563
pmc: PMC8085482
doi:

Banques de données

ClinicalTrials.gov
['NCT02889133']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2285-2298

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL133049
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL148151
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 by The American Society of Hematology.

Références

Transfusion. 2006 Jan;46(1):143-52
pubmed: 16398744
Surg Gynecol Obstet. 1988 Jan;166(1):33-46
pubmed: 3122334
Blood Transfus. 2017 May;15(3):239-248
pubmed: 28518051
Lancet. 2008 Oct 18;372(9647):1411-26
pubmed: 18940465
Blood Transfus. 2019 Jul;17(4):274-280
pubmed: 31385800
J Clin Invest. 2017 Jan 3;127(1):375-382
pubmed: 27941245
J Exp Med. 1919 Feb 28;29(3):267-81
pubmed: 19868318
Transfusion. 2012 Aug;52(8):1827-35
pubmed: 22229278
Transfus Apher Sci. 2010 Aug;43(1):51-9
pubmed: 20558107
Ann Emerg Med. 2019 Jun;73(6):650-661
pubmed: 30447946
Haematologica. 2012 Jan;97(1):107-15
pubmed: 21993682
Front Med (Lausanne). 2018 May 15;5:130
pubmed: 29868587
Nouv Rev Fr Hematol. 1972 Nov-Dec;12(6):721-45
pubmed: 4268780
Haematologia (Budap). 1985;18(4):233-48
pubmed: 3836159
Malar J. 2018 Oct 19;17(1):371
pubmed: 30340592
Transfusion. 2008 Sep;48(9):1943-53
pubmed: 18564399
Crit Care Med. 2018 Dec;46(12):e1097-e1104
pubmed: 30234568
Blood Transfus. 2019 Jan;17(1):27-52
pubmed: 30653459
Transfusion. 2015 Jan;55(1):205-19
pubmed: 25130459
Transfusion. 2019 Jul;59(7):2264-2275
pubmed: 31002399
Transfusion. 1969 Sep-Oct;9(5):229-37
pubmed: 4898470
Transfusion. 1968 Mar-Apr;8(2):65-73
pubmed: 4966896
Transfus Med. 2012 Apr;22(2):90-6
pubmed: 22394111
Blood. 2019 Sep 26;134(13):1003-1013
pubmed: 31350268
Transfusion. 2014 Jan;54(1):137-48
pubmed: 23721209
Transfus Apher Sci. 2002 Dec;27(3):233-8
pubmed: 12509218
Transfusion. 1999 Sep;39(9):991-7
pubmed: 10533826
Vox Sang. 2017 Apr;112(3):268-278
pubmed: 28220494
N Engl J Med. 2016 Nov 17;375(20):1937-1945
pubmed: 27775503
Transfusion. 2009 Dec;49(12):2599-603
pubmed: 20163690
Transfusion. 2016 Jun;56(6):1462-8
pubmed: 27080455
Transfus Apher Sci. 2015 Jun;52(3):270-6
pubmed: 25982219
Vox Sang. 1985;48(5):257-68
pubmed: 3992966
Transfusion. 2021 Mar;61(3):903-918
pubmed: 33381865
J Cell Biol. 1977 Jun;73(3):548-60
pubmed: 873988
J Clin Invest. 1955 Oct;34(10):1509-12
pubmed: 13263430
Transfusion. 2008 Jul;48(7):1478-85
pubmed: 18482180
Transfusion. 2018 Aug;58(8):1870-1880
pubmed: 29665067
N Engl J Med. 2015 Apr 9;372(15):1419-29
pubmed: 25853746
Am J Physiol. 1996 Dec;271(6 Pt 1):C1847-52
pubmed: 8997184
Transfusion. 2009 Mar;49(3):458-64
pubmed: 19171002
Lancet Haematol. 2017 Nov;4(11):e544-e552
pubmed: 29021123
Blood. 2010 May 27;115(21):4284-92
pubmed: 20299509
Transfusion. 2020 Nov;60(11):2633-2646
pubmed: 32812244
Front Med (Lausanne). 2018 May 30;5:164
pubmed: 29900172
Transfusion. 2019 Jun;59(6):1945-1952
pubmed: 30793325
J Lab Clin Med. 1966 Jun;67(6):955-65
pubmed: 5916144
Transfusion. 2014 Dec;54(12):3186-97
pubmed: 25041478
Malar J. 2012 Apr 27;11:135
pubmed: 22540175
Transfus Med Rev. 2002 Oct;16(4):283-95
pubmed: 12415514
Transfus Clin Biol. 1994;1(3):188-91
pubmed: 8044314
PLoS One. 2014 Aug 28;9(8):e105692
pubmed: 25167052
Transfus Med Rev. 1999 Oct;13(4):275-96
pubmed: 10553271
Vox Sang. 1990;58(2):90-3
pubmed: 2111063
Blood. 2012 Jul 12;120(2):424-30
pubmed: 22510876
Br J Haematol. 1994 Jun;87(2):363-8
pubmed: 7947280
Transfus Med Rev. 2018 Apr;32(2):77-88
pubmed: 29526337
Front Immunol. 2017 Oct 30;8:1425
pubmed: 29163500
J Surg Res. 2002 Jan;102(1):6-12
pubmed: 11792145
Blood. 2006 May 1;107(9):3745-52
pubmed: 16384927
Transfusion. 2017 Apr;57(4):1007-1018
pubmed: 28150311
Transfusion. 2019 Jan;59(1):79-88
pubmed: 30408207
N Engl J Med. 2015 Apr 9;372(15):1410-8
pubmed: 25853745
Transfus Sci. 1994 Jun;15(2):105-15
pubmed: 10147356
Transfusion. 2016 Jan;56(1):146-52
pubmed: 26417725
Vox Sang. 2014 Apr;106(3):219-26
pubmed: 24117950
Transfusion. 2017 Apr;57(4):1019-1030
pubmed: 28295356
Transfusion. 1984 Mar-Apr;24(2):109-14
pubmed: 6710582
Am J Hematol. 2018 May;93(5):E110-E112
pubmed: 29352741
N Engl J Med. 2017 Nov 9;377(19):1858-1867
pubmed: 28952891
Blood. 2008 Sep 15;112(6):2520-8
pubmed: 18579796
Microvasc Res. 1991 Jul;42(1):60-76
pubmed: 1921755
JAMA. 2015 Dec 15;314(23):2514-23
pubmed: 26637812
Transfusion. 2006 Jan;46(1):137-42
pubmed: 16398743
Vox Sang. 2006 Oct;91(3):244-51
pubmed: 16958837
Transfusion. 2019 May;59(5):1620-1623
pubmed: 30865302
Transfusion. 2015 Mar;55(3):491-8
pubmed: 25233911
Transfusion. 2008 Jun;48(6):1053-60
pubmed: 18298603

Auteurs

Camille Roussel (C)

U1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM, Université de Paris, Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.
UMR_S1134, Biologie Intégrée du Globule Rouge, INSERM, Université de Paris, Paris, France.
Institut National de la Transfusion Sanguine, Paris, France.

Alexandre Morel (A)

U1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM, Université de Paris, Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.
Département d'Hématologie, Hôpital Universitaire Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Michaël Dussiot (M)

U1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM, Université de Paris, Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.

Mickaël Marin (M)

Laboratoire d'Excellence GR-Ex, Paris, France.
UMR_S1134, Biologie Intégrée du Globule Rouge, INSERM, Université de Paris, Paris, France.
Institut National de la Transfusion Sanguine, Paris, France.

Martin Colard (M)

U1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM, Université de Paris, Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.

Aurélie Fricot-Monsinjon (A)

Laboratoire d'Excellence GR-Ex, Paris, France.
UMR_S1134, Biologie Intégrée du Globule Rouge, INSERM, Université de Paris, Paris, France.
Institut National de la Transfusion Sanguine, Paris, France.

Anaïs Martinez (A)

U1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM, Université de Paris, Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.

Charlotte Chambrion (C)

Laboratoire d'Excellence GR-Ex, Paris, France.
UMR_S1134, Biologie Intégrée du Globule Rouge, INSERM, Université de Paris, Paris, France.
Institut National de la Transfusion Sanguine, Paris, France.

Benoît Henry (B)

Laboratoire d'Excellence GR-Ex, Paris, France.
UMR_S1134, Biologie Intégrée du Globule Rouge, INSERM, Université de Paris, Paris, France.
Institut National de la Transfusion Sanguine, Paris, France.

Madeleine Casimir (M)

U1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM, Université de Paris, Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.

Geoffroy Volle (G)

Laboratoire d'Excellence GR-Ex, Paris, France.
UMR_S1134, Biologie Intégrée du Globule Rouge, INSERM, Université de Paris, Paris, France.
Institut National de la Transfusion Sanguine, Paris, France.

Mallorie Dépond (M)

Laboratoire d'Excellence GR-Ex, Paris, France.
UMR_S1134, Biologie Intégrée du Globule Rouge, INSERM, Université de Paris, Paris, France.
Institut National de la Transfusion Sanguine, Paris, France.

Safi Dokmak (S)

Department of Hepatobiliary Surgery and Liver Transplantation, Hôpital Beaujon, AP-HP, Clichy, France.

François Paye (F)

Department of Digestive Surgery, Hôpital Saint-Antoine, AP-HP, Paris, France.

Alain Sauvanet (A)

Department of Hepatobiliary Surgery and Liver Transplantation, Hôpital Beaujon, AP-HP, Clichy, France.

Caroline Le Van Kim (C)

Laboratoire d'Excellence GR-Ex, Paris, France.
UMR_S1134, Biologie Intégrée du Globule Rouge, INSERM, Université de Paris, Paris, France.
Institut National de la Transfusion Sanguine, Paris, France.

Yves Colin (Y)

Laboratoire d'Excellence GR-Ex, Paris, France.
UMR_S1134, Biologie Intégrée du Globule Rouge, INSERM, Université de Paris, Paris, France.
Institut National de la Transfusion Sanguine, Paris, France.

Sonia Georgeault (S)

Plateforme des Microscopies, Infrastructures de Recherche en Biologie Santé et Agronomie, Programme PluriFormation Analyse des Systèmes Biologiques and.

Philippe Roingeard (P)

Plateforme des Microscopies, Infrastructures de Recherche en Biologie Santé et Agronomie, Programme PluriFormation Analyse des Systèmes Biologiques and.
U1259, Morphogenèse et Antigénicité du VIH et des Virus des Hépatites, INSERM, Université de Tours and Centre Hospitalier Régional Universitaire (CHRU) de Tours, Tours, France.

Steven L Spitalnik (SL)

Department of Pathology and Cell Biology, Irving Medical Center, Columbia University, New York, NY; and.

Papa Alioune Ndour (PA)

Laboratoire d'Excellence GR-Ex, Paris, France.
UMR_S1134, Biologie Intégrée du Globule Rouge, INSERM, Université de Paris, Paris, France.
Institut National de la Transfusion Sanguine, Paris, France.

Olivier Hermine (O)

U1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM, Université de Paris, Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.
Département d'Hématologie, Hôpital Universitaire Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Eldad A Hod (EA)

Department of Pathology and Cell Biology, Irving Medical Center, Columbia University, New York, NY; and.

Pierre A Buffet (PA)

Laboratoire d'Excellence GR-Ex, Paris, France.
UMR_S1134, Biologie Intégrée du Globule Rouge, INSERM, Université de Paris, Paris, France.
Institut National de la Transfusion Sanguine, Paris, France.
AP-HP, Paris, France.

Pascal Amireault (P)

U1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM, Université de Paris, Paris, France.
Laboratoire d'Excellence GR-Ex, Paris, France.
UMR_S1134, Biologie Intégrée du Globule Rouge, INSERM, Université de Paris, Paris, France.
Institut National de la Transfusion Sanguine, Paris, France.

Articles similaires

Humans Male Female Anemia Myocardial Infarction
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH